Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. OptiBiotix Health Share Price
  4. OptiBiotix Health Share Regulatory News
  5. Notice of Results

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

OptiBiotix Health Information

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.125
Bid: 17.75
Ask: 18.50
Change: 0.125 (0.69%)
Spread: 0.75 (4.225%)
Open: 18.00
High: 18.125
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

23 Mar 2016 07:00

RNS Number : 9494S
OptiBiotix Health PLC
23 March 2016
 

23 March 2016

OptiBiotix Health Plc

 

Notice of Results

Analyst Briefing

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its preliminary results for the year ended 30 November 2015 on Thursday 14 April 2016.

 

A briefing for analysts will take place in the Gresham room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW at 9.30am on Thursday 14 April 2016.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.

 

 

 For further information:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below

Cairn Financial Advisers LLP

Tel: 020 7148 7900

Liam Murray / Avi Robinson

Hybridan LLP (Joint Broker)

Claire Louise Noyce

Tel: 020 3764 2341

Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFFRVTIFFIR
12345678910
Date   Source Headline
2nd Aug 20167:00 amRNSAppointment of Director of Business Development
28th Jul 20162:30 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSCompletion of pilot launch and creation of JV
14th Jul 20167:00 amRNSNew patent filing
5th Jul 20167:00 amRNSStrategy update
4th Jul 20163:36 pmRNSHolding(s) in Company
30th Jun 20163:06 pmRNSExercise of Warrants and Issue of Equity
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
2nd Jun 201612:18 pmRNSExercise of Warrants and Issue of Equity
19th May 20167:00 amRNSNew patent filing
10th May 201612:39 pmRNSResult of AGM
20th Apr 201612:18 pmRNSExercise of Warrants and Issue of Equity
14th Apr 20167:00 amRNSFinal Results
7th Apr 20167:00 amRNSResults of cholesterol human volunteer study
5th Apr 20167:00 amRNSJoint development agreement signed with Royal DSM
24th Mar 20167:00 amRNSExercise of Warrants and Issue of Equity
23rd Mar 20167:00 amRNSNotice of Results
22nd Mar 20167:00 amRNSSecond contract signed for Sweetbiotix
17th Mar 20167:00 amRNSJV agreement with the University of Manchester
26th Feb 201610:57 amRNSExercise of Warrants and Issue of Equity
19th Feb 201610:12 amRNSExercise of Warrants and Issue of Equity
12th Feb 20169:49 amRNSExercise of Warrants and Issue of Equity
5th Feb 20167:00 amRNSPlacing
28th Jan 201612:51 pmRNSInvestor presentation - change of venue
26th Jan 20167:00 amRNSExercise of Warrants and Issue of Equity
20th Jan 20167:00 amRNSInvestor presentation
19th Jan 20167:00 amRNSScientific Advisory Group appointment
13th Jan 20167:00 amRNSCommercial agreement signed with KSF Acquisition
21st Dec 20157:00 amRNSCompletion of Placing, Total Voting Rights
11th Dec 20151:30 pmRNSCorrection: Exercise of Warrants & Issue of Equity
11th Dec 201511:30 amRNSExercise of Warrants and Issue of Equity
7th Dec 20157:00 amRNSPlacing and Directors' Dealings
24th Nov 20157:00 amRNSDirectorate Change
20th Nov 20157:00 amRNSDevelopment agreement signed with CSL
16th Nov 201510:49 amRNSExercise of Warrants and Issue of Equity
5th Nov 20154:40 pmRNSSecond Price Monitoring Extn
5th Nov 20154:35 pmRNSPrice Monitoring Extension
3rd Nov 20157:00 amRNSNew patent filings
7th Oct 201512:30 pmRNSHolding(s) in Company
7th Oct 20157:00 amRNSNew microbial strain registrations
29th Sep 20157:00 amRNSCompletion of human studies
18th Sep 20154:18 pmRNSExercise of Warrants and Issue of Equity
27th Aug 20157:00 amRNSHalf Yearly Report
11th Aug 201512:08 pmRNSResult of AGM
28th Jul 20157:00 amRNSCompletion of human studies
9th Jul 20157:00 amRNSContract signed with Instituto de Química Orgánica
23rd Jun 20155:00 pmRNSHolding(s) in Company
17th Jun 20154:59 pmRNSExercise of Warrants and Issue of Equity
12th Jun 20152:05 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.